PURPOSE: To estimate and compare the costs of scleral buckle (SB) and pars plana vitrectomy (PPV) for treatment of rhegmatogenous retinal detachment (RRD). DESIGN: Cost analysis based on published prospective data comparing SB and PPV for RRD repair. METHODS: The costs of initial surgery, postoperative retina-affecting procedures, and eventual cataract extraction resulting from SB and PPV for RRD repair were estimated for both phakic and pseudophakic or aphakic patients and then were compared. A univariate sensitivity analysis also was performed to examine the sensitivity of our estimations. RESULTS: When considering all costs, SB was 10.7% less expensive than PPV for RRD repair in phakic patients, whereas PPV was 12% less expensive than SB for RRD repair in pseudophakic or aphakic patients. These conclusions were robust in the sensitivity analysis. CONCLUSIONS: SB seems to offer a modest cost savings over PPV for repair of RRD in phakic patients. However, in pseudophakic and aphakic patients, PPV seems to be less expensive than SB.
PURPOSE: To estimate and compare the costs of scleral buckle (SB) and pars plana vitrectomy (PPV) for treatment of rhegmatogenous retinal detachment (RRD). DESIGN: Cost analysis based on published prospective data comparing SB and PPV for RRD repair. METHODS: The costs of initial surgery, postoperative retina-affecting procedures, and eventual cataract extraction resulting from SB and PPV for RRD repair were estimated for both phakic and pseudophakic or aphakic patients and then were compared. A univariate sensitivity analysis also was performed to examine the sensitivity of our estimations. RESULTS: When considering all costs, SB was 10.7% less expensive than PPV for RRD repair in phakic patients, whereas PPV was 12% less expensive than SB for RRD repair in pseudophakic or aphakic patients. These conclusions were robust in the sensitivity analysis. CONCLUSIONS: SB seems to offer a modest cost savings over PPV for repair of RRD in phakic patients. However, in pseudophakic and aphakic patients, PPV seems to be less expensive than SB.
Authors: Shelley Day; Daniel S Grossman; Prithvi Mruthyunjaya; Frank A Sloan; Paul P Lee Journal: Am J Ophthalmol Date: 2010-06-29 Impact factor: 5.258
Authors: Eric D Weichel; Adam Martidis; Mitchell S Fineman; J Arch McNamara; Carl H Park; James F Vander; Allen C Ho; Gary C Brown Journal: Ophthalmology Date: 2006-11 Impact factor: 12.079
Authors: Vincenza Bonfiglio; Mario D Toro; Antonio Longo; Teresio Avitabile; Robert Rejdak; Katarzyna Nowomiejska; Tomasz Choragiewicz; Andrea Russo; Matteo Fallico; Agnieszka Kaminska; Elina Ortisi; Stefano Zenoni; Michele Reibaldi Journal: J Ophthalmol Date: 2018-10-23 Impact factor: 1.909